| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/26/1994 | US5332727 Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
| 07/26/1994 | US5332672 Prevention of ES cell differentiation by ciliary neurotrophic factor |
| 07/26/1994 | US5332582 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/26/1994 | US5332575 Binding a product to a membrane |
| 07/26/1994 | US5332567 Detection and treatment of infections with immunoconjugates |
| 07/26/1994 | CA2114243A1 Drug composition and process for preparing the same |
| 07/26/1994 | CA2114153A1 Antithrombin composition and process for preparation thereof |
| 07/26/1994 | CA2114152A1 Antithrombin composition and process for preparation thereof |
| 07/26/1994 | CA1331020C Medicament with improved penetration of the tissue membrane |
| 07/26/1994 | CA1330943C Growth inhibiting agent and the use thereof |
| 07/26/1994 | CA1330942C Controlled release delivery coating formulation for bioactive substances |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015953A1 Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015643A1 Readily available konjac glucomannan sustained release excipient |
| 07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015636A1 Vaccine preparations |
| 07/21/1994 | WO1994015635A1 Inducing cytotoxic t lymphocyte responses |
| 07/21/1994 | WO1994015631A1 Dry plasminogen preparation |
| 07/21/1994 | WO1994015614A1 Antiviral topical pharmaceutical compositions |
| 07/21/1994 | WO1994015609A1 Enhanced pharmaceutical compositions for skin penetration |
| 07/21/1994 | WO1994015597A1 Ophthalmic compositions comprising benzyllauryldimethylammonium chloride |
| 07/21/1994 | WO1994015587A2 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
| 07/21/1994 | WO1994015584A1 Solution containing igf-1 |
| 07/21/1994 | WO1994015582A1 Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor |
| 07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | WO1994012219A3 Modified insulin-like growth factors |
| 07/21/1994 | WO1994009625A3 Stabilization of fluorocarbon emulsions |
| 07/21/1994 | WO1994007536A3 Alginate-bioactive agent conjugates |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
| 07/21/1994 | CA2153268A1 Topical compositions for the eye comprising a .beta.-cyclodextrin derivative and a therapeutic agent |
| 07/21/1994 | CA2153166A1 Enhanced pharmaceutical compositions for skin penetration |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
| 07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | CA2150574A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/20/1994 | EP0606925A2 A method for derivatizing a 1-amino-1-deoxyoligosaccharide |
| 07/20/1994 | EP0606753A2 Non-reducing saccharide-forming enzyme, and its preparation and uses |
| 07/20/1994 | EP0606742A1 Bile acid sequestrant |
| 07/20/1994 | EP0606457A1 Vaginal mucoadhesive gel, medicament containing it and its method of preparation |
| 07/20/1994 | EP0606411A1 Novel compounds and conjugates |
| 07/20/1994 | EP0606280A1 New conjugates for the introduction of nucleic acid into higher eukaryotic cells |
| 07/20/1994 | EP0606219A1 Wound cleanser |
| 07/20/1994 | EP0605536A4 Fatty acid terminated polyanhydrides. |
| 07/20/1994 | EP0325616B1 Penetration enhancers for transdermal delivery of systemic agents |
| 07/20/1994 | CN1089624A Carboxybinil polymer which shows newtonian viscosity |
| 07/20/1994 | CN1089507A Basa agent and drug composition thereof which are taken through cutis |
| 07/19/1994 | US5330979 Method of treating renal disorders with inositoltriphosphate |
| 07/19/1994 | US5330762 Tandospiaine antidepressive therapy |
| 07/19/1994 | US5330742 Methods and compositions for magnetic resonance imaging |
| 07/19/1994 | US5330681 Stable emulsions of perfluoropolyethers |
| 07/19/1994 | CA1330791C Oral delivery system |
| 07/19/1994 | CA1330757C Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 07/13/1994 | EP0605963A2 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 07/13/1994 | EP0605753A1 Cyclodextrin inclusion complex of taxol, and method for its production and its use |
| 07/13/1994 | EP0605704A1 Starch-iodine-peroxide preservation of blood, tissues and biological fluids |
| 07/13/1994 | EP0605646A1 Sparfloxacine salts and solutions containing same |
| 07/13/1994 | EP0605536A1 Fatty acid terminated polyanhydrides |
| 07/13/1994 | EP0605497A1 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln). |
| 07/13/1994 | EP0605489A1 Modified peptide derivatives |
| 07/13/1994 | EP0605477A1 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 07/13/1994 | EP0387352B1 Enteric formulations of physiologically active peptides and proteins |
| 07/13/1994 | CN1089156A Ointment for burn and scald and preparing technology thereof |
| 07/13/1994 | CN1089138A 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 07/13/1994 | CN1089137A Injectable mesna solutions |
| 07/12/1994 | US5328996 DNA as anticoagulants |
| 07/12/1994 | US5328985 Recombinant streptavidin-protein chimeras useful for conjugation of molecules in the immune system |
| 07/12/1994 | US5328955 Using a hydrophilic polyethylene |
| 07/12/1994 | US5328903 Containing mannitol or sugar, hydroxypropyl cellulose, and polyvinylpyrrolidone or hydroxymethyl celulose; stabilization, uniform distribution |
| 07/12/1994 | US5328837 Hepatocyte growth factor protease domain variants |
| 07/12/1994 | US5328697 Compositions and processes for the sustained release of drugs |
| 07/12/1994 | US5328694 Stable injectable solution of factor VIII |
| 07/12/1994 | US5328690 Polyamino acid dispersants |
| 07/12/1994 | US5328681 Composition comprising magnetic metal oxide ultrafine particles and derivatized polysaccharides |
| 07/12/1994 | US5328680 Hydroxy, iodo benzamides for angiography |
| 07/12/1994 | US5328470 Catheter |
| 07/12/1994 | CA1330650C Process for the stabilization of hydrated lipidic lamellar phases, for example liposomes, liposome composition, composition of hydrated lipidic lamellar phases, for example liposomes, stabilized by employing an atelocollagene- and glycosaminoglycan-based stabilizing support, and utilization thereof in pharmacy or in ... |
| 07/07/1994 | WO1994015028A1 Runway-maintenance device |
| 07/07/1994 | WO1994014976A1 Immune response modulator complex, and uses thereof |
| 07/07/1994 | WO1994014475A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT |
| 07/07/1994 | WO1994014472A1 Method for inhibition of cell adhesion to receptors containing selectins |
| 07/07/1994 | WO1994014468A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/07/1994 | WO1994014466A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
| 07/07/1994 | WO1994014465A1 Stable lyophilized pharmaceutical preparations g-csf |
| 07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
| 07/07/1994 | WO1994014426A1 Atovaquone pharmaceutical compositions |
| 07/07/1994 | WO1994014423A1 Enhanced solubility pharmaceutical solutions |
| 07/07/1994 | WO1994014420A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
| 07/07/1994 | WO1994014417A1 Plasticized bioerodible controlled delivery system |
| 07/07/1994 | WO1994014416A1 Bioerodible controlled delivery system |
| 07/07/1994 | WO1994014415A1 Fluorocarbon emulsions |
| 07/07/1994 | WO1994014412A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| 07/07/1994 | WO1994011508A3 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 07/07/1994 | WO1994010317A3 Conjugate vaccine against group b streptococcus |
| 07/07/1994 | WO1993022433A3 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |